IRVINE, Calif. - March 11, 2021
The Boards received an update from the Transportation Corridor Agencies’ (TCA) Communications department including recent earned media coverage, news releases, social media, industry recognition and a new video highlighting TCA’s cattle grazing program. Below are two of the items covered in the presentation:
The Boards had an in-depth discussion about various pieces of legislation with a focus on those sponsored by Senators Josh Newman (SB 623) and Pat Bates (SB 760/761). SB 623, supported by both Boards, is the outcome of a statewide coalition of transportation agencies and focuses on protecting consumer privacy and ensuring efficient toll operations. The Boards expressed several concerns regarding the need and transportation policy impact SB 760/761 would have on Orange County and across the state but expressed a willingness to allow Senator Bates to address the concerns. During the deliberations there were many comments and actions taken by the Boards that sought to continue the successful collaboration that has occurred at the local level. The Boards took action to appoint Director Heft and direct the CEO to share the Boards’ concerns and ideas with the Senator and for the Chairs to establish a working group to develop consensus solutions to address the concerns of South County member cities and resolve ongoing litigation.
CEO Samuel Johnson announced that, as requested by the Boards, TCA operations staff reached out and strengthened its partnership with the California Highway Patrol to provide increased targeted enforcement to promote good driving behaviors on The Toll Roads. He also highlighted how TCA will advance a communications plan to support the effort and remind drivers that personal safety and the safety of others should be everyone’s priority.
As a government agency, the health and safety of the public are important to us and we are committed to complying with efforts to slow the spread of COVID-19.
For the latest on our response to COVID-19, visit TheTollRoads.com/COVID-19.